Strategikon Announces Clinical Maestro 2.4


Strategikon Pharma announced a major update to their Clinical Maestro platform including features that target clinical trial planning and sourcing. This release, Clinical Maestro CORETM, focuses on expanding the ease of use and flexibility for Contract Research Organizations and other clinical service providers who need to quickly create accurate bids.

Clinical Maestro CORE is a configurable, cloud-based SaaS solution combining clinical study and services assumptions with complex costing algorithms that aim to produce clinical study budgets faster and more reliably than traditional Excel-based methods.

More on Clinical Maestro 2.4

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.